v3 Template
N

Nexalin Technology, Inc.

Healthcare / NeuroHealth Houston, TX, USA ~300 employees
Founded
--
Employees (Est.)
~300
15 leaders known
Total Funding
$20.5M
Funding Rounds
4
Last Funding
2025-05-06

About Nexalin Technology, Inc.

Nexalin Technology is a leader in NeuroHealth, focusing on addressing mental health issues such as anxiety, insomnia, depression, addiction, and early dementia through a patented, frequency-based waveform technology. Their Nexalin device, which is FDA-cleared, non-invasive, and medication-free, interacts with deep centers of the midbrain to normalize neurochemicals, aiming to improve quality of life.

Products & Services

Nexalin Device:An FDA-cleared, non-invasive device that uses a frequency-based waveform to treat mental health conditions like anxiety and insomnia by normalizing brain neurochemicals. Treatment lasts 40 minutes and can be done at home with no side effects.

Specialties

NeuroHealth Brain Health Technology Non-Invasive Mental Health Treatment Frequency-Based Waveform Therapy

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Underwritten Public Offering
T: -
FT: Underwritten Public Offering
A: 5000000
MR: -
FA: 5.0 million
FAN: 5000000
D: 2025-05-06
FD: 2025-05-06
1 investors
2 RT: Public Offering
T: -
FT: Public Offering
A: 5000000
MR: -
FA: approximately $5.0 million
FAN: 5000000
D: 2025-05-05
FD: 2025-05-05
1 investors
3 RT: Public Offering
T: -
FT: Public Offering
A: 5250000
MR: -
FA: $5,250,000
FAN: 5250000
D: 2024-07-01
FD: 2024-07-01
1 investors
4 RT: Public Offering
T: -
FT: Public Offering
A: 5250000
MR: -
FA: $5,250,000
FAN: 5250000
D: 2024-06-27
FD: 2024-06-27
1 investors
Underwritten Public Offering Latest
2025-05-06
$5.0M
1 investor (Pro only)
Public Offering 2025-05-05
$5.0M
Public Offering 2024-07-01
$5.2M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Mark White

President and Chief Executive Officer, Board of Directors

D

David Owens, M.D.

Chief Medical Officer, Board of Directors, Scientific Advisory Board

M

Marilyn Elson

Controller

C

Carolyn Shelton

Chief Operations Officer & EVP of Clinical, Quality & Regulatory Affairs

J

John Patrick Claude

Director of Engineering, Research and Development

L

Leslie Bernhard

Chairman of the Board, Nominating & Corporate Governance Committee Chairman, Audit Committee Chairman, Compensation Committee

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

Nexalin Technology, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / NeuroHealth
Company Size
~300 employees (est.)
Locations
Houston, TX, USA
Houston, TX

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro